News
iBio Signs License Agreement with Planet Biotechnology for COVID-19 Therapeutic
iBio Inc., a biotechnology innovator and biologics contract manufacturing organization, has entered into an exclusive worldwide license agreement with Planet Biotechnology Inc. for the development of Planet’s COVID-19 therapeutic candidate, ACE2-Fc.
ACE2-Fc is a recombinant protein comprised of human angiotensin...
News
CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management
CluePoints S.A., a provider of Risk-Based Study Execution (RBx) and Data Quality Oversight software for clinical trials, announced a minority investment from Summit Partners, a global growth equity investor with $21 billion in assets under management. Summit will support...
News
CDMO Ology Bioservices Wins $106M Army Contract for COVID-19 Vaccine Manufacturing Support
Ology Bioservices, a biologics contract development and manufacturing organization (CDMO), has been awarded a contract by the U.S. Army Contracting Command, located in Aberdeen Proving Ground, MD. The contract ceiling value is $106.3 million, of which $53.1 million was...
News
Softbox donates thermal covers for safe delivery of vital medicines to the Democratic Republic of the Congo
Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has helped protect temperature-sensitive shipments of essential medicines to the Democratic Republic of the Congo (DRC) in...
News
Cambridge University aims for autumn coronavirus vaccine trials after UK funding
The University of Cambridge is aiming to start clinical trials of its possible coronavirus vaccine in the autumn after it received 1.9 million pounds ($2.5 million) in funding from the British government, the university said. The scientists behind the...
Clinical Trials
Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India
Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune.
We have screened some patients. Tomorrow, we will...
Clinical Trials
Australian COVID-19 vaccine shows promising results in animal trials
A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results against the novel coronavirus in preclinical tests, raising hopes for its potential effectiveness and manufacturability, the varsity said on Wednesday.
According to the yet-to-be published...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read